zopiclone has been researched along with Benign Neoplasms in 3 studies
zopiclone: S(+)-enantiomer of racemic zopiclone; azabicyclo(4.3.0)nonane; a nonbenzodiazepine; one of the so-called of Z drugs (zopiclone, eszopiclone, zolpidem, and zaleplon) for which there is some correlation with tumors; was term of zopiclone 2004-2007
zopiclone : A pyrrolo[3,4-b]pyrazine compound having a 4-methylpiperazine-1-carboxyl group at the 5-position, a 5-chloropyridin-2-yl group at the 6-position and an oxo-substituent at the 7-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Insomnia is frequent in patients with advanced cancer, and a variety of pharmacological agents is used to treat this condition." | 3.11 | Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer-a double-blind, randomized placebo-controlled clinical multicenter phase IV trial. ( Hjermstad, MJ; Jakobsen, G; Kaasa, S; Klepstad, P; Paulsen, Ø; Sjue, K, 2022) |
| "Despite the high prevalence of insomnia in patients with advanced cancer, there are no randomized controlled trials on pharmacological interventions for insomnia in this group of patients." | 2.87 | Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer: study protocol for a double-blind, randomized, placebo-controlled, clinical multicenter trial. ( Engstrøm, M; Fayers, P; Hjermstad, MJ; Jakobsen, G; Kaasa, S; Klepstad, P; Paulsen, Ø; Raj, SX; Sjue, K; Thronæs, M, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jakobsen, G | 2 |
| Sjue, K | 2 |
| Paulsen, Ø | 2 |
| Kaasa, S | 2 |
| Hjermstad, MJ | 2 |
| Klepstad, P | 2 |
| Engstrøm, M | 1 |
| Raj, SX | 1 |
| Thronæs, M | 1 |
| Fayers, P | 1 |
| Stebbing, J | 1 |
| Waters, L | 1 |
| Davies, L | 1 |
| Mandalia, S | 1 |
| Nelson, M | 1 |
| Gazzard, B | 1 |
| Bower, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pharmacological Treatment of Insomnia in Palliative Care: A Randomized, Double-blind, Placebo Controlled, Parallel-group, Multicenter Trial Investigating the Short Time Effect of Zopiclone on Self-reported Sleep Quality in Patients With Advanced Cancer Wh[NCT02807922] | Phase 4 | 43 participants (Actual) | Interventional | 2016-11-15 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for zopiclone and Benign Neoplasms
| Article | Year |
|---|---|
Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer-a double-blind, randomized placebo-controlled clinical multicenter phase IV trial.
Topics: Adult; Aged; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Neoplasms; Piperazi | 2022 |
Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer: study protocol for a double-blind, randomized, placebo-controlled, clinical multicenter trial.
Topics: Azabicyclo Compounds; Clinical Trials, Phase IV as Topic; Double-Blind Method; Drug Administration S | 2018 |
1 other study available for zopiclone and Benign Neoplasms
| Article | Year |
|---|---|
Incidence of cancer in individuals receiving chronic zopiclone or eszopiclone requires prospective study.
Topics: Azabicyclo Compounds; Female; HIV Infections; HIV-1; Humans; Incidence; Male; Neoplasms; Piperazines | 2005 |